Related Experiment Videos

Neonatal screening for congenital adrenal hyperplasia using a microfilter paper method for

Hormone Research
|January 1, 1982
PubMed

Insights

Newborn screening for 21-hydroxylase deficiency using 17-hydroxyprogesterone (17-OHP) assays in Italy identified a prevalence of 1 in 5,558 infants. This study highlights the effectiveness of early detection for congenital adrenal hyperplasia.

Area of Science:

  • Endocrinology
  • Neonatal Screening
  • Genetics

Background:

  • Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting the adrenal glands.
  • 21-hydroxylase deficiency is the most common form of CAH, leading to hormonal imbalances.
  • Early detection through newborn screening is crucial for timely intervention and management.

Purpose of the Study:

  • To determine the incidence of 21-hydroxylase deficiency in a large cohort of newborns in Emilia-Romagna, Italy.
  • To evaluate the efficacy of 17-hydroxyprogesterone (17-OHP) screening in identifying cases of 21-hydroxylase deficiency.
  • To establish population-specific prevalence data for this condition.

Main Methods:

  • Analysis of 22,233 capillary blood samples collected on filter paper from newborns.
  • Measurement of 17-hydroxyprogesterone (17-OHP) levels using a modified micromethod.
  • Implementation of a two-tier assay system with a threshold of 20 pg/disk for initial screening and confirmation.

Main Results:

  • A total of 22,233 infants were screened for 17-OHP levels.
  • 0.18% of cases required a second assay due to elevated initial 17-OHP values.
  • Pathologic 17-OHP levels were confirmed in 4 neonates, indicating an incidence of 1 in 5,558 for 21-hydroxylase deficiency.

Conclusions:

  • The study established the incidence of 21-hydroxylase deficiency in the Emilia-Romagna region of Italy.
  • Newborn screening using 17-OHP assays is an effective method for detecting this condition.
  • The findings contribute valuable epidemiological data for CAH.

Related Concept Videos